Early decrease of T-bet+ B cells during subcutaneous belimumab predicts response to therapy in systemic lupus erythematosus patients.
La Gualana F, Olivieri G, Petriti B, Picciariello L, Natalucci F, Sciannamea M, Gragnani L, Basile U, Casato M, Spinelli FR, Stefanini L, Basili S, Visentini M, Ceccarelli F, Conti F.
La Gualana F, et al. Among authors: sciannamea m.
Immunol Lett. 2024 Dec 4;272:106962. doi: 10.1016/j.imlet.2024.106962. Online ahead of print.
Immunol Lett. 2024.
PMID: 39643119